Loading...
Loading...
Medical imaging (X-ray, CT, MRI), electronic health records, clinical trials, ECG/EEG, pathology
13,041 datasets
European Union data from the Dutch Ministry of the Interior and Kingdom Relations tracks the historical growth of health expenditure from 1996 to 2023. The dataset provides both nominal and real growth figures, with expenditures corrected for major budget transfers and technical adjustments. It is published under a CC0 1.0 license.
School health services in the Netherlands collect parental questionnaires and professional interviews on child health and development. Reports aggregate data at the municipal level for the province of Groningen, covering body weight, eyes, ears, and mental health. The data is provided by the Dutch Ministry of the Interior and Kingdom Relations.
Kayla R. Duxbury's 5.5 KB dataset analyzes the impact of a sire's infection status on disease transmission to pups. The outcome variable is pup diagnostic positivity, with sire positivity via qPCR or serology during the birth year as the exposure. Missing sire diagnostic data is noted for specific pup identifiers 111, 132, 263, 284, 375, and 416.
A 36.2% mortality rate was observed among 67 elderly patients with advanced heart failure over an 18-month follow-up period. Mauricio Manrique-Samer conducted this prospective observational study at a tertiary hospital's Heart Failure Clinic between September 2020 and March 2024. The research assessed the predictive value of the LEVO-D score for clinical outcomes like hospitalization and mortality.
Huma Rani published a study on April 10, 2026, comparing Frank and Clayton copula models. The work analyzes interdependencies between clinical variables, specifically overall survival and age at diagnosis, using data from the METABRIC breast cancer dataset.
Copula regression models jointly analyze overall survival and age at diagnosis in breast cancer patients. The dataset likely contains clinical variables from the METABRIC study, used to compare Gaussian and Gumbel copula models. Author Huma Rani published the analysis on figshare under CC-BY-4.0 license.
Japanese intensive care units (ICU) are the focus of this dataset, which contains a culturally adapted nurse-led intervention program to improve the quality of dying and death. The program was developed through systematic reviews and validated via expert interviews and web-based surveys. The dataset, authored by Kazuaki Naya and last updated in April 2026, is shared under a CC-BY-4.0 license.
Kazuaki Naya's dataset contains participant characteristics for a study developing a culturally adapted nurse-led intervention to improve the quality of dying and death in Japanese intensive care units. The dataset is 5.5 KB in size, stored in an XLS file, and was last updated on April 10, 2026. It is licensed under CC-BY-4.0 and hosted on figshare.
A 5.5 KB Excel file containing an interview guide for evaluating a nurse-led intervention program. The guide was developed by Kazuaki Naya and last updated in April 2026 to assess the clarity, feasibility, and cultural alignment of strategies for improving end-of-life care in Japanese intensive care units.
A prospective single-arm biomarker pilot study investigating the prognostic and predictive potential of multiparametric 18F-FDG LAFOV-PET for first-line chemo-immunotherapy efficacy in advanced non-small-cell lung cancer. The study, authored by Margaux Geier, opened for enrolment in January 2025 and plans to include 120 patients at 2 French sites over a 2-year inclusion period. The dataset contains the study's inclusion and exclusion criteria.
388 filters from 54 children requiring continuous renal replacement therapy (CRRT) were analyzed in a retrospective study from a pediatric ICU in Nancy, France. The median filter lifespan was 13.3 hours for patients with hemolytic uremic syndrome (HUS), compared to 17.6 hours for patients with other etiologies. The dataset supports analysis of filter longevity by disease group and anticoagulation type, with no significant difference found between regional citrate and heparin in HUS patients.
A dataset from the Greater London Authority, last updated on 2026-06-24. It likely contains statistics on qualifications, health, disability, and care provision. The data is aggregated at the Lower Layer Super Output Area (LSOA) level for the United Kingdom.
UK government contracts, commissioned activities, purchase orders, and framework agreements with a value exceeding £5,000, published by the Government Digital Service. Data is published quarterly and has been redacted in line with Local Government Association guidance to protect personal data, commercial confidentiality, and security. The dataset is available in CSV and JSON formats.
1992 marks the start of this dataset, which reports drug utilization for outpatient drugs paid for by state Medicaid agencies. It is provided by the U.S. Department of Health & Human Services and includes state, drug name, National Drug Code, prescription counts, and reimbursement dollars. The data is sourced from the Medicaid Drug Rebate Program.
United States state-level data tracks covered outpatient drugs paid for by Medicaid agencies. The dataset includes drug name, National Drug Code, number of prescriptions, and dollars reimbursed per state. It supports analysis of pharmaceutical utilization and spending patterns within the Medicaid program.
State Drug Utilization Data contains records of covered outpatient drugs paid for by state Medicaid agencies under the Medicaid Drug Rebate Program. The data likely includes state, drug name, National Drug Code (NDC), number of prescriptions, and dollars reimbursed. It is reported by states and serves as a source for analyzing drug spending and utilization patterns within the Medicaid program.
State-reported data covers outpatient drugs paid for by Medicaid agencies since the start of the Medicaid Drug Rebate Program. The dataset includes state, drug name, National Drug Code, number of prescriptions, and dollars reimbursed for the year 2004. It is provided by the U.S. Department of Health & Human Services and was last updated on the platform in April 2026.
State-reported data tracks outpatient drug prescriptions paid for by Medicaid agencies. The dataset includes drug names, National Drug Codes, prescription counts, and dollars reimbursed for the year 2019. It originates from the U.S. Department of Health & Human Services and was last updated on the platform in April 2026.
U.S. state-level data on Medicaid-covered outpatient drug utilization from 2002. The dataset includes drug names, National Drug Codes, prescription counts, and reimbursement amounts, reported by state Medicaid agencies. It is provided by the U.S. Department of Health & Human Services and was last updated in April 2026.
State-reported data on covered outpatient drugs paid for by Medicaid agencies since the start of the Medicaid Drug Rebate Program. The dataset includes state, drug name, National Drug Code, number of prescriptions, and dollars reimbursed. It is provided by the U.S. Department of Health & Human Services and was last updated in April 2026.